Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
Home Plan Tips for Seniors - 2Scientists solve the mystery of 'impossible' merger of 'forbidden' black holes
- 3Israeli forces kill one person in series of attacks on southern Lebanon
- 4The most effective method to Refresh the Infotainment Framework in the Volvo XC40
- 5France's Senate backs ban on social media platforms for under-15s
- Vote in favor of your Number one kind of juice
- Find the Advantages of Positive Nurturing: Supporting Cheerful and Sound Kids
- Transform the daily grind to make life more interesting – a philosopher shares 3 strategies to help you attain the good life
- 2025 Was Another Exceptionally Hot Year
- Visual communication Programming for Fledglings
- Track down the Ideal Weight reduction Methodology for Your Way of life
- 'Not the moon that I'm used to seeing': Artemis II astronauts describe seeing the far side
- France to build new nuclear aircraft carrier, Macron says
- Well known Worldwide Caf\u00e9s to Experience
